News

Archive: December, 2022

Senior Response Leaders Shown Latest Chemical, Biological Defense Technology Available for Disaster Response
December 22, 2022 — A group of senior leaders responsible for carrying out national disasters responses were recently shown the latest capabilities for responding to chemical, biological, radiological and nuclear (CBRN) events. On November 30, personnel from the Joint Program Executive Office for CBRN Defense along with the Air Force CBRN Defense Systems Branch and the Uniformed Services University’s 4DBio Program demonstrated current and future CBRN defense capabilities to a senior leadership team comprised of representatives from the White House’s Office of Science and Technology Policy, the National Security Council’s Office for Resilience and Response, the Defense Threat Reduction Agency, the Federal Emergency Management Agency (FEMA), and additional domestic emergency response organizations... MORE

Senior response leaders learn about the joint expeditionary collective protection family of systems available in the event of chemical or biological event

DoD Funds Production of More Life-Saving Medicine for Use After Nerve Agent Exposure
December 22, 2022 — The Defense Department's office responsible for acquiring medical countermeasures against chemical, biological, radiological and nuclear (CBRN) threats has awarded an agreement for the production of more life-saving nerve agent exposure treatments. The Joint Project Manager for CBRN Medical (JPM CBRN Medical) awarded a follow-on other transaction authority production agreement to Rafa Laboratories, Ltd. (Rafa) to manufacture and deliver 10mg midazolam injection autoinjectors to the Joint Force beginning December 2022. The midazolam injection autoinjector is indicated to treat prolonged seizures in adults, which can occur after exposure to a nerve agent. This new Advanced Anticonvulsant System (AAS) improves upon, and will eventually replace, the currently fielded Convulsant Antidote for Nerve Agent (CANA) diazepam autoinjector. Fielding the midazolam injection autoinjector gives the warfighter and the Nation access to a life-saving medical countermeasure in CBRN environments... MORE

3d CR Troopers test new protection garments
December 14, 2022 — 3d Cavalry Regiment Troopers took part in testing new Chemical, Biological, Radiation, and Nuclear protection garments here Dec. 5-8. The Chemical, Biological Duty Uniform (CBDU), is still in the testing phase but is projected to replace the Joint Service Lightweight Integrated Suit Technology (JSLIST) and fielded in the next few years. Features of the new CBDU improve on the fitting, comfort, weight, temperature regulation, and CBRN protection – much needed upgrades from the JSLIST Troopers are currently fielded, according to Tiffany Swidrak, a test support analyst for the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense – General Purpose team... MORE

A U.S. Army Trooper assigned to 3d Cavalry Regiment assumes a kneeling position with a dummy rifle while testing newly designed chemical, biological, radiation, and nuclear protection equipment Dec. 8, 2022, at Fort Hood, Texas. (U.S. Army photo by Staff Sgt. Christopher Stewart)

NSWC Crane employee serves public health overseeing $900M portfolio as U.S. expands vaccine and therapeutic manufacturing supply chain
December 14, 2022 — A Naval Surface Warfare Center, Crane Division (NSWC Crane) employee is serving on a detail overseeing a $900 million portfolio to expand the U.S. vaccine and therapeutic manufacturing supply chain. Over the past two years, these investments and partnerships with industry have developed into the construction of new manufacturing facilities across the country to develop future vaccine and therapeutic capabilities. The JPEO-CBRND and the Army Contracting Command were leveraged to assist the Biomedical Advanced Research and Development Authority, which is an office in the U.S. Department of Health and Human Services, who were tasked in 2020 to ensure that every COVID-19 vaccine, therapeutic, and test kit were bought, packaged, and delivered to the Nation. The JPEO-CBRND has a special Joint Assisted Acquisition (JA2) team, established by the May 2021 memorandum of understanding between DoD and HHS, which supports the continued contracting and acquisition expertise needed for the Nation’s ongoing mission to fight the coronavirus, including partnerships with the Federal COVID-19 Response interagency team, academia and the American industrial base... MORE

Naval Surface Warfare Center, Crane Division - Heather Baladi, NSWC Crane

News Search

News Archive - Search by Year and Month

October 2023 (1)
September 2023 (5)
August 2023 (8)
July 2023 (2)
June 2023 (2)
May 2023 (3)
April 2023 (2)
March 2023 (1)
February 2023 (1)
January 2023 (1)
December 2022 (4)
November 2022 (1)
October 2022 (3)
September 2022 (5)
August 2022 (3)
July 2022 (3)
June 2022 (1)
May 2022 (1)
March 2022 (2)
February 2022 (2)
January 2022 (5)
December 2021 (1)
November 2021 (6)
October 2021 (2)
September 2021 (1)
July 2021 (1)
June 2021 (1)
May 2021 (8)
April 2021 (6)
March 2021 (2)
February 2021 (5)
January 2021 (4)
December 2020 (3)
November 2020 (1)
August 2020 (1)
July 2020 (3)
May 2020 (1)
April 2020 (1)
March 2020 (4)
February 2020 (1)
December 2019 (2)
November 2019 (2)
October 2019 (2)
September 2019 (2)
March 2019 (1)
January 2019 (2)
December 2018 (1)
October 2018 (1)
July 2018 (1)
April 2018 (1)
February 2018 (1)
December 2017 (1)
November 2017 (2)
September 2017 (1)
June 2017 (2)
January 2017 (3)
December 2016 (1)

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.